Particle-stabilized epitopes for standardization and control...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/37

G01N 33/531 (2006.01) G01N 33/543 (2006.01) G01N 33/546 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01) G01N 33/92 (2006.01)

Patent

CA 1340139

The invention relates to a process for preparing standards and controls for immunoassays employing monoclonal antibodies. Monoclonal antibodies are used to isolate a restricted portion of an antigen containing an epitope that determines the specifity of the monoclonal antibody-antigen reaction so as to distinguish it from the antigen as a whole following fragmentation of the complex antigen by procedures including proteolysis. Isolated epitopes are attached covalently or by physical adsorption to particles to immobilize and stabilize the epitope. The particles can be composed of iodipamide ethyl ester, polyvinyl chloride polystyrene and other inert substances and can be chemically activated to improve epitope binding and stability. Experimental details demonstrate the binding of lipoprotein epitopes to IDE, polyvinyl chloride and polystyrene and the subsequent reaction of monoclonal antibodies to these particle-stabilized epitopes.

579307

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Particle-stabilized epitopes for standardization and control... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Particle-stabilized epitopes for standardization and control..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Particle-stabilized epitopes for standardization and control... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1269264

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.